Cargando…
The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable and fatal neurodegenerative disease characterized by the loss of motor neurons. Despite substantial research, the causes of ALS remain unclear. Glycoprotein nonmetastatic melanoma protein B (GPNMB) was identified as an ALS-related factor using DNA...
Autores principales: | Tanaka, Hirotaka, Shimazawa, Masamitsu, Kimura, Masataka, Takata, Masafumi, Tsuruma, Kazuhiro, Yamada, Mitsunori, Takahashi, Hitoshi, Hozumi, Isao, Niwa, Jun-ichi, Iguchi, Yohei, Nikawa, Takeshi, Sobue, Gen, Inuzuka, Takashi, Hara, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417778/ https://www.ncbi.nlm.nih.gov/pubmed/22891158 http://dx.doi.org/10.1038/srep00573 |
Ejemplares similares
-
GPNMB Induces BiP Expression by Enhancing Splicing of BiP Pre-mRNA during the Endoplasmic Reticulum Stress Response
por: Noda, Yasuhiro, et al.
Publicado: (2017) -
Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na(+)/K(+)-ATPase
por: Ono, Yoko, et al.
Publicado: (2016) -
An Inducer of VGF Protects Cells against ER Stress-Induced Cell Death and Prolongs Survival in the Mutant SOD1 Animal Models of Familial ALS
por: Shimazawa, Masamitsu, et al.
Publicado: (2010) -
VGF and striatal cell damage in in vitro and in vivo models of Huntington’s disease
por: Noda, Yasuhiro, et al.
Publicado: (2015) -
Comparison of bee products based on assays of antioxidant capacities
por: Nakajima, Yoshimi, et al.
Publicado: (2009)